ArticleMedical oncology (Northwood, London, England)2025
5-Bromouracil-gracillin (5BrU-G) complex: an APOBEC3-activated therapeutic strategy exploiting cancer-specific enzymatic activity for selective cytotoxicity.
Mays S Hatim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.